These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36576926)

  • 1. A rehabilitation program to increase balance and mobility in ataxia of Charlevoix-Saguenay: An exploratory study.
    Lessard I; Masterman V; Côté I; Gagnon C; Duchesne E
    PLoS One; 2022; 17(12):e0279406. PubMed ID: 36576926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional mobility in walking adult population with ataxia of Charlevoix-Saguenay.
    Lessard I; St-Gelais R; Hébert LJ; Côté I; Mathieu J; Brais B; Gagnon C
    Orphanet J Rare Dis; 2021 Oct; 16(1):432. PubMed ID: 34649570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay: a 4-Year Longitudinal Study.
    Lessard I; Côté I; St-Gelais R; Hébert LJ; Brais B; Mathieu J; Rodrigue X; Gagnon C
    Cerebellum; 2024 Apr; 23(2):489-501. PubMed ID: 37101017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Orphanet J Rare Dis; 2018 Sep; 13(1):165. PubMed ID: 30231904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory natural history of ataxia of Charlevoix-Saguenay: A 2-year follow-up.
    Gagnon C; Lessard I; Lavoie C; Côté I; St-Gelais R; Mathieu J; Brais B
    Neurology; 2018 Oct; 91(14):e1307-e1311. PubMed ID: 30158165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Neurology; 2019 Oct; 93(16):e1543-e1549. PubMed ID: 31534027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wheelchair mobility, motor performance and participation of adult wheelchair users with ARSACS: a cross-sectional study.
    Bourassa J; Routhier F; Gagnon C; Rahn C; Hébert LJ; St-Gelais R; Rodrigue X; Brais B; Best KL
    Disabil Rehabil Assist Technol; 2023 May; 18(4):378-386. PubMed ID: 33307884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing mobility and balance in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay population: Validity and reliability of four outcome measures.
    Lessard I; Brais B; Côté I; Lavoie C; Synofzik M; Mathieu J; Gagnon C
    J Neurol Sci; 2018 Jul; 390():4-9. PubMed ID: 29801904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation and Functional Independence in Adults With Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Muslemani S; Lessard I; Lavoie C; Côté I; Brais B; Mathieu J; Gagnon C
    Can J Occup Ther; 2022 Sep; 89(3):315-325. PubMed ID: 35469466
    [No Abstract]   [Full Text] [Related]  

  • 10. Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.
    Tremblay M; Girard-Côté L; Brais B; Gagnon C
    Orphanet J Rare Dis; 2022 Oct; 17(1):369. PubMed ID: 36183078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a Better Understanding of Walking Speed in Ataxia of Charlevoix-Saguenay: a Factor Exploratory Study.
    Lessard I; Hébert LJ; St-Gelais R; Côté I; Mathieu J; Brais B; Gagnon C
    Cerebellum; 2023 Dec; ():. PubMed ID: 38133849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement properties of wheelchair use assessment tools in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Bourassa J; Best KL; Gagnon C; Hébert LJ; Brais B; Routhier F
    Disabil Rehabil Assist Technol; 2022 Nov; 17(8):907-915. PubMed ID: 32981404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use in patients with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Beauchesne W; Ouellet-Dupuis F; Frigon MA; Savard C; Gagné-Ouellet V; Gagnon C; Tremblay K
    J Clin Neurosci; 2022 Sep; 103():44-48. PubMed ID: 35809457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) - A Polish family with novel SACS mutations.
    Krygier M; Konkel A; Schinwelski M; Rydzanicz M; Walczak A; Sildatke-Bauer M; Płoski R; Sławek J
    Neurol Neurochir Pol; 2017; 51(6):481-485. PubMed ID: 28843771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Bourcier D; Bélanger M; Côté I; Brais B; Synofzik M; Brisson JD; Rodrigue X; Gagnon MM; Mathieu J; Gagnon C
    J Neurol Sci; 2020 Oct; 417():117050. PubMed ID: 32736199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.
    Rezende Filho FM; Bremner F; Pedroso JL; de Andrade JBC; Marianelli BF; Lourenço CM; Marques-Júnior W; França MC; Kok F; Sallum JMF; Parkinson MH; Barsottini OG; Giunti P
    Mov Disord; 2021 Sep; 36(9):2027-2035. PubMed ID: 33893680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the LEMOCOT in the adult ARSACS population: A measure of lower limb coordination.
    Lessard I; Lavoie C; Côté I; Mathieu J; Brais B; Gagnon C
    J Neurol Sci; 2017 Jun; 377():193-196. PubMed ID: 28477695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Discriminative, Convergent, and Ecological Validity in a Multicenter Study (PROSPAX).
    Beichert L; Ilg W; Kessler C; Traschütz A; Reich S; Santorelli FM; Başak AN; Gagnon C; ; Schüle R; Synofzik M
    Mov Disord; 2024 Jun; ():. PubMed ID: 38847438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel SACS p.Pro4154GlnfsTer20 mutation in a family with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Samanci B; Gokalp EE; Bilgic B; Gurvit H; Artan S; Hanagasi HA
    Neurol Sci; 2021 Jul; 42(7):2969-2973. PubMed ID: 33559790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.